Total Payments
$3,815
2022 Payments
$34.41
Companies
30
Transactions
129
Medicare Patients
1,241
Medicare Billing
$147,231
Payment Breakdown by Category
Food & Beverage$3,044 (79.8%)
Travel$759.33 (19.9%)
Consulting$11.76 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,044 | 126 | 79.8% |
| Travel and Lodging | $759.33 | 2 | 19.9% |
| Consulting Fee | $11.76 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,382 | 9 | $0 (2017) |
| Novo Nordisk Inc | $304.96 | 21 | $0 (2022) |
| PFIZER INC. | $291.43 | 16 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $215.80 | 4 | $0 (2020) |
| Astellas Pharma US Inc | $213.00 | 12 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $157.26 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $147.10 | 7 | $0 (2020) |
| AbbVie Inc. | $130.42 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $113.86 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $111.33 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $34.41 | 2 | Lilly USA, LLC ($20.75) |
| 2021 | $64.31 | 3 | AbbVie Inc. ($25.36) |
| 2020 | $225.76 | 8 | Janssen Pharmaceuticals, Inc ($100.00) |
| 2019 | $796.57 | 41 | Novo Nordisk Inc ($121.00) |
| 2018 | $581.54 | 23 | E.R. Squibb & Sons, L.L.C. ($131.00) |
| 2017 | $2,112 | 52 | Medtronic Vascular, Inc. ($1,382) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.66 | General |
| 09/15/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 08/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 03/06/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Cardiovascular | ||||||
| 03/05/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: UROLOGY | ||||||
| 02/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/17/2020 | PFIZER INC. | CHANTIX (Drug), LYRICA, FLECTOR | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
| 01/28/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Virology & Specialty Care | ||||||
| 01/10/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2019 | Novo Nordisk Inc | Ozempic (Drug), Tresiba, RYBELSUS | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
| 12/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: DIABETES | ||||||
| 12/16/2019 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/10/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Bone Health | ||||||
| 12/06/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Cardiovascular | ||||||
| 12/02/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: UROLOGY | ||||||
| 11/22/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiology | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.59 | General |
| 11/18/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.59 | General |
| 11/18/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.59 | General |
| 11/11/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 472 | 644 | $185,100 | $56,786 |
| 2022 | 7 | 246 | 368 | $105,081 | $33,706 |
| 2021 | 4 | 174 | 247 | $45,251 | $25,757 |
| 2020 | 10 | 349 | 436 | $65,171 | $30,981 |
Total Patients
1,241
Total Services
1,695
Medicare Billing
$147,231
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 328 | $113,160 | $32,103 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 62 | 62 | $21,948 | $8,702 | 39.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $6,237 | $3,102 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 43 | $10,535 | $3,015 | 28.6% |
| 77067 | Screening mammography | Office | 2023 | 25 | 25 | $9,200 | $2,722 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $10,728 | $2,386 | 22.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $2,660 | $1,516 | 57.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $720.00 | $705.60 | 98.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 18 | 18 | $1,598 | $646.18 | 40.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $420.00 | $411.60 | 98.0% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 11 | 11 | $2,008 | $403.81 | 20.1% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 12 | 16 | $2,000 | $387.14 | 19.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 19 | $2,755 | $372.47 | 13.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 29 | $1,131 | $313.08 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 222 | $76,590 | $22,679 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $13,452 | $5,564 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 28 | $6,860 | $1,954 | 28.5% |
| 77067 | Screening mammography | Office | 2022 | 17 | 17 | $6,256 | $1,916 | 30.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 16 | $1,040 | $1,022 | 98.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 16 | $480.00 | $479.62 | 99.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 25 | 31 | $403.00 | $91.98 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 99 | 172 | $33,540 | $17,806 | 53.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $10,481 | $6,999 | 66.8% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 17 | 17 | $900.00 | $737.74 | 82.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $330.00 | $214.39 | 65.0% |
About Dr. Victoria Leigh, D.O
Dr. Victoria Leigh, D.O is a Internal Medicine healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1619372265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Victoria Leigh, D.O has received a total of $3,815 in payments from pharmaceutical and medical device companies, with $34.41 received in 2022. These payments were reported across 129 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,044).
As a Medicare-enrolled provider, Leigh has provided services to 1,241 Medicare beneficiaries, totaling 1,695 services with total Medicare billing of $147,231. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Long Beach, CA
- Active Since 10/24/2014
- Last Updated 11/05/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619372265
Products in Payments
- CHANTIX (Drug) $216.21
- XARELTO (Drug) $215.80
- ELIQUIS (Drug) $176.03
- CareLink (Device) $164.04
- MYRBETRIQ (Drug) $149.00
- ENTRESTO (Drug) $147.10
- Victoza (Drug) $128.24
- BREATHTEK (Device) $113.86
- FARXIGA (Drug) $111.33
- Ozempic (Drug) $72.59
- FLUZONE HIGH-DOSE (Drug) $71.51
- TRULICITY (Drug) $69.30
- SPRIX (Drug) $60.96
- Corlanor (Drug) $44.78
- Myrbetriq (Drug) $39.35
- QVAR (Drug) $37.44
- Horizant (Drug) $37.10
- LifeVest (Device) $35.28
- JANUVIA (Drug) $34.02
- LINZESS (Drug) $30.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Long Beach
Jennifer Connelly, D.o, D.O
Internal Medicine — Payments: $275,877
Internal Medicine $275,877
Dr. Mark Lee, Md, MD
Internal Medicine — Payments: $142,649
Internal Medicine $142,649
Dr. Mark Leibowitz, M.d, M.D
Internal Medicine — Payments: $103,211
Internal Medicine $103,211
Dr. Steven Appleby, Md, MD
Internal Medicine — Payments: $101,644
Internal Medicine $101,644
Dr. Milan Sheth, Md, MD
Internal Medicine — Payments: $71,682
Internal Medicine $71,682
Katya Corado, M.d, M.D
Internal Medicine — Payments: $30,357
Internal Medicine $30,357